The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II clinical trial with long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 (IL2) in patients with high risk neuroblastoma.
 
Holger N. Lode
Consulting or Advisory Role - Apeiron Biologics
 
Dominique Valteau-Couanet
No Relationships to Disclose
 
Sascha Troschke-Meurer
No Relationships to Disclose
 
Carla Manzitti
No Relationships to Disclose
 
Juliet Gray
No Relationships to Disclose
 
Victoria Castel
No Relationships to Disclose
 
Isaac Yaniv
No Relationships to Disclose
 
Hans Loibner
Employment - Apeiron Biologics
Leadership - Apeiron Biologics
Stock and Other Ownership Interests - Apeiron Biologics
Honoraria - Apeiron Biologics
Consulting or Advisory Role - Apeiron Biologics
Patents, Royalties, Other Intellectual Property - Apeiron Biologics
 
Nikolai Siebert
No Relationships to Disclose
 
Evgenia Glogova
No Relationships to Disclose
 
Ulrike Poetschger
No Relationships to Disclose
 
Ruth Ladenstein
Consulting or Advisory Role - Apeiron Biologics